We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH Appeals Guidance Needs More Clarity, Detail: AdvaMed
CDRH Appeals Guidance Needs More Clarity, Detail: AdvaMed
August 30, 2013
AdvaMed is asking the FDA to clarify the steps in CDRH’s appeals process and how devicemakers can access it, in the only comments filed on the draft guidance before the comment period closed on Aug. 15.